South Korea IVD Markets, 2023-2024 and 2028: Focus on Reagents, Consumables, Calibrators, and Controls

News provided by

Mar 20, 2024, 05:15 ET

DUBLIN, March 20, 2024 /PRNewswire/ -- The "The IVD Market in South Korea, 2024" report has been added to ResearchAndMarkets.com's offering.

The IVD Market in South Korea, 2024 offers a comprehensive overview of the in vitro diagnostics (IVD) market in South Korea and the factors shaping it.

The report presents South Korea's IVD revenues for 2023 and forecasts for 2028, segmented into clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology/cytology. Included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.

The report is designed to provide the reader with an overview of the IVD market in South Korea and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators, and controls of the following sub-segments:

Clinical Chemistry: routine lab testing; substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC). Includes urinalysis and blood chemistry testing. Hematology and hemoglobin tests are also included in this segment.
Immunoassays: hormones and thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology and common infectious diseases (HIV, hepatitis, influenza).
Microbiology and Molecular Testing: manual and automated tests, culture media (to be prepared or ready to use), latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma, nucleic acid testing.
Point-of-Care Testing: all POC tests for cardiology, toxicology, coagulation, diabetes, infectious diseases. Includes POC and non-POC blood gas and electrolytes. Also includes glucose self-monitoring tests.
Histology/Cytology: PAP, HE, IHC, ISH, FISH, primary and secondary antibodies.

Key Topics Covered:

Chapter 1: Executive Summary

Industry Overview
Scope and Methodology
South Korea Ivd Market Summary
Company Profiles

Chapter 2: South Korea Overview

Population
Health Indicators
General Health
Disease Profiles in South Korea
Economy and Health Spending
Health Infrastructure
Medical Facilities
Hospital Bed Density
Physicians
Medical Tourism
Medical Device Regulation
Regulatory News
Precision Medicine and Ngs
Physician Shortage in South Korea

Chapter 3: Ivd Markets in South Korea

Market Summary
Clinical Chemistry
Hematology
Hemoglobin
Blood Gas Analysis
Urinalysis
Immunoassay
Non-Infectious Disease Immunoassays
Infectious Disease Immunoassays
Blood Bank Screening Immunoassays
Microbiology/Molecular
Id/Ast
Molecular Diagnostics
Blood Screening
Point-Of-Care
Poc Glucose
Poc Infectious Disease
Histology
Hpv
Ctc

Chapter 4: Major Market Participants

Abbott Laboratories
Becton Dickinson (Bd)
Bertis, Inc.
Bio-Rad Laboratories Inc.
Biomerieux SA
Danaher Corporation
Fujirebio Inc.
Gencurix
Roche Diagnostic Corporation
Sd Biosensor
Seegene, Inc.
Siemens Healthineers GmbH
Sugentech
Sysmex Corporation
Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/r/ax0web

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets